Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1614959rdf:typepubmed:Citationlld:pubmed
pubmed-article:1614959lifeskim:mentionsumls-concept:C0085104lld:lifeskim
pubmed-article:1614959lifeskim:mentionsumls-concept:C0085174lld:lifeskim
pubmed-article:1614959lifeskim:mentionsumls-concept:C0006935lld:lifeskim
pubmed-article:1614959pubmed:issue3lld:pubmed
pubmed-article:1614959pubmed:dateCreated1992-7-24lld:pubmed
pubmed-article:1614959pubmed:abstractTextA bilayer floating dosage unit is proposed to achieve local delivery of misoprostol, a prostaglandin E1 analogue, at the gastric mucosa level. The system is a capsule consisting of a floating layer maintaining the dosage unit buoyant upon the gastric content and a drug layer formulated to act as a sustained-delivery system. The differential design of the two layers allows the optimization of both floating capability and drug release profile. The layers are both composed of a hydrophilic matrix based upon hydroxypropylmethyl cellulose (HPMC). Parameters influencing the release profiles are described. The use of a large capsule increases the gastric residence time (GRT), as it impedes passage through the pylorus opening. gamma-Scintigraphic studies were performed to visualize cohesion of the two layers in vivo and to determine GRT as a function of meal regimen. The average GRTs were 199 +/- 69 min after a single meal (breakfast) and 618 +/- 208 min after a succession of meals.lld:pubmed
pubmed-article:1614959pubmed:languageenglld:pubmed
pubmed-article:1614959pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1614959pubmed:citationSubsetIMlld:pubmed
pubmed-article:1614959pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1614959pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1614959pubmed:statusMEDLINElld:pubmed
pubmed-article:1614959pubmed:monthMarlld:pubmed
pubmed-article:1614959pubmed:issn0724-8741lld:pubmed
pubmed-article:1614959pubmed:authorpubmed-author:OttAAlld:pubmed
pubmed-article:1614959pubmed:authorpubmed-author:TimmermansJJlld:pubmed
pubmed-article:1614959pubmed:authorpubmed-author:FranzMMlld:pubmed
pubmed-article:1614959pubmed:authorpubmed-author:MöesAAlld:pubmed
pubmed-article:1614959pubmed:issnTypePrintlld:pubmed
pubmed-article:1614959pubmed:volume9lld:pubmed
pubmed-article:1614959pubmed:ownerNLMlld:pubmed
pubmed-article:1614959pubmed:authorsCompleteYlld:pubmed
pubmed-article:1614959pubmed:pagination298-302lld:pubmed
pubmed-article:1614959pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:meshHeadingpubmed-meshheading:1614959-...lld:pubmed
pubmed-article:1614959pubmed:year1992lld:pubmed
pubmed-article:1614959pubmed:articleTitleThe bilayer floating capsule: a stomach-directed drug delivery system for misoprostol.lld:pubmed
pubmed-article:1614959pubmed:affiliationSearle European Development Centre, Mont-Saint-Guibert, Belgium.lld:pubmed
pubmed-article:1614959pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1614959lld:pubmed